Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
India Blood Transfusion Products Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type, Automated Technologies, Cell Therapy Technologies), Whole Blood Technology,, Leukocyte Depletion Filters,, Buffy Coat Pooling System), By End User, and By End User Type and Country Forecast 2020-2031
India Blood Transfusion Products Market size was valued at US$ 73.5 million in 2024 and is expected to reach US$ 104.1 million by 2031, growing at a significant CAGR of 5.1% from 2025-2031. The market thrives on a constant and critical demand for blood transfusions. Every two seconds in India, a blood transfusion occurs, highlighting the urgency of this need. This translates to a staggering annual requirement of 14.6 million blood units. Unfortunately, the current supply struggles to keep pace, with a persistent shortfall of one million units plaguing the healthcare system. Several factors contribute to this high demand. India's vast population inherently necessitates a larger blood supply for various medical procedures, surgeries, and treatments for conditions like thalassemia.
Additionally, the growing adoption of advanced medical procedures requiring blood transfusions, such as organ transplants and complex surgeries, further pushes the demand upwards. Finally, increased public awareness regarding the benefits of blood donation and blood transfusion therapy will lead to more patients seeking these procedures, further intensifying the demand. The government is actively addressing this gap through various initiatives. The "Raktdaan Amrit Mahotsav" campaign aims to promote voluntary blood donation and bridge the supply-demand divide. This campaign, coupled with the E-Rakt Kosh portal, a centralized blood bank management system, showcases the government's commitment to improving blood management in India. The E-Rakt Kosh portal efficiently manages donor records, facilitates blood type matching, and expedites allocation, ensuring faster delivery of blood products to hospitals in need. In conclusion, the high demand for blood transfusions in India presents a significant opportunity for the blood transfusion medicine market.
The market is projected to reach US$ 121.9 million by 2034 due to the growing burden of diseases such as cancer, anemia, and thalassemia has led to an increased demand for blood transfusion services in both public and private healthcare settings. As the incidence of these diseases rises, the need for safe and timely access to blood products becomes paramount, driving the growth of the blood transfusion medicine market. Increasing healthcare expenditure, coupled with growing disposable incomes and health insurance coverage, has enabled individuals to access a wider range of healthcare services, including blood transfusion.
India carries a substantial burden of hemoglobinopathies, with thalassemia being the most prevalent. This genetic blood disorder presents in different severities (minor, major, intermedia) based on the imbalance of alpha and beta-globin chains. The estimated number of diagnosed β-thalassemia major patients in India is 100,000 but the true figure is likely higher due to the absence of a National Patient Registry. Alarmingly, India contributes to roughly 25% of the global β-thalassemia burden. Around 42 million people in India are carriers, unknowingly harboring the faulty gene that can be passed on to offspring. An estimated 10,000 new cases of thalassemia major, a severe form requiring lifelong blood transfusions, are reported annually.
The prevalence varies across regions, with the highest concentration in Eastern and Western India. For instance, the β-thalassemia trait prevalence in South India ranges from 8.5% to 37.9%, while the β-thalassemia major cases range from 2.3% to 7.4%. The scheduled castes, scheduled tribes, and other backward classes with lower socioeconomic status and literacy rates are disproportionately affected. Despite being reported in almost all states, the disease is concentrated in the eastern and western regions. The lack of mandatory prenatal screening and limited access in rural areas pose significant challenges for prevention. To effectively reduce the thalassemia burden, well-coordinated national and state strategies are essential. Increased public education and awareness campaigns, mandatory prenatal screening programs, accessible genetic counseling facilities, and cost-effective diagnostic tests, particularly in rural areas, are crucial steps towards prevention. The future growth of the thalassemic population is likely to remain significant and will drive the India blood transfusion medicine market in the upcoming years.
Report Benchmarks |
Details |
Market Size in 2024 |
US$ 73.5 million |
Market Size in 2031 |
US$ 104.1 million |
By Product Type |
|
By End User |
|
By End User Type |
|
Download Free Sample Report
The India blood transfusion products market size was valued at US$ 73.5 million in 2024 and is expected to reach US$ 104.1 million by 2031, growing at a significant CAGR of 5.1% from 2025-2031.
Technological solutions for blood availability and distribution, educational campaigns and workforce development, and addressing platelet demand surge during dengue outbreaks are expected to provide opportunities to the market players in the market growth over the forecast period.
The leading players in the India blood transfusion medicine market are Terumo Corporation, Fresenius Kabi, Haemonetics Corporation, Mitra Industries Private Limited and others
1. Executive Summary |
2. India Blood Transfusion Products Market Introduction |
2.1. India Blood Transfusion Products Market - Taxonomy |
2.2. India Blood Transfusion Products Market - Definitions |
2.2.1. Product Type |
2.2.2. End User |
2.2.3. End User Type |
3. India Blood Transfusion Products Market Dynamics |
3.1. India Blood Transfusion Products Market - Macro-Economic Factors |
3.2. India Blood Transfusion Products Market Dynamic Factors - Impact Analysis |
3.3. India Blood Transfusion Products Market Dynamic Factors – Market Background |
3.3.1. Drivers and Restraints |
3.3.2. Opportunities/Unmet Needs of the Market & Trends |
3.4. Value Added Insights (USPs) |
4. India Blood Transfusion Products Market Demand (in Value or Size in US$ Mn) Analysis 2020 - 2024 and Forecast 2025 - 2031 |
5. India Blood Transfusion Products Market By Product Type, 2020 - 2024 and Forecast 2025-2031 (Sales Value USD Million) |
5.1. Instrument Type |
5.1.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.1.1. Apheresis Devices |
5.1.1.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.1.1.2 Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3 Market Opportunity Analysis |
5.1.2 Automated Technologies |
5.1.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Cell Therapy Technologies (Cell Washing and Processing) |
5.1.3.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.2. Whole Blood Technology |
5.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.2.1 Blood Bags |
5.2.1.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.2.1.2 Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3 Market Opportunity Analysis |
5.2.2. Inline Filter Blood Bags |
5.2.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.2.2.2 Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3. Leukocyte Depletion Filters |
5.2.3.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3 Market Opportunity Analysis |
5.2.4. Buffy Coat Pooling System |
5.2.4.1 Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
5.2.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.4.3. Market Opportunity Analysis |
6. India Blood Transfusion Products Market By End User, 2020 - 2024 and Forecast 2025-2031 (Sales Value USD Million) |
6.1. Hospital Chains |
6 1 1 Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Standalone Hospitals |
6.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Blood Centers |
6.3.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. India Blood Transfusion Products Market By End User Type, 2020 - 2024 and Forecast 2025-2031 (Sales Value USD Million) |
7.1. Public |
7.1.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Private |
7.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Competition Landscape |
8.1. Company Share Analysis (2023) |
8.2. Strategic Dashboard of Top Market Players |
8.3. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
8.3.1. Terumo Corporation |
8.3.2. Fresenius Kabi |
8.3.3. Haemonetics Corporation |
8.3.4. Asahi Kasei Medical Co., Ltd. |
8.3.5. Mallinckrodt Pharmaceuticals |
8.3.6. Polymedicure |
8.3.7. Mitra Industries Private Limited |
8.3.8. Narang Medical Limited. |
8.3.9. RENOLIT SE |
8.3.10. AdvaCare Pharma |
8.3.11. Naugra Medical Lab |
8.3.12. Macopharma |
8.3.13. PIT Medical Systems |
9. Research Methodology |
10. Key Assumptions and Acronyms |
List of Figures: India Blood Transfusion Products Market |
Figure 01: India Blood Transfusion Products Market Revenue Share (%), by Product Type (2023 A) |
Figure 02: India Blood Transfusion Products Market Y-o-Y Growth (%), by End User, 2024-2034 |
Figure 03: India Blood Transfusion Products Market Revenue (US$ Mn), by End User Type (2023 A, and 2034 F) |
Figure 04: India Blood Transfusion Products Market Revenue Share (%) by End User Type (2023 A) |
Figure 05: India Blood Transfusion Products Market Y-o-Y Growth (%), 2024-2034 |
Figure 06: India Blood Transfusion Products Market Value Analysis (US$ Mn), 2019–2034 |
Figure 07: India Blood Transfusion Products Market Incremental $ Opportunity, 2024-2034 |
Figure 08: India Blood Transfusion Products Market Share Analysis (%), By Product Type, 2024 (E) & 2034 (F) |
Figure 09: India Blood Transfusion Products Market Y-o-Y Analysis (%), By Product Type, 2024-2034 |
Figure 10: India Blood Transfusion Products Market - Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2019 - 2034 |
Figure 11: India Blood Transfusion Products Market Attractiveness Analysis By Product Type, 2024–2034 |
Figure 12: India Blood Transfusion Products Market Share Analysis (%), By End User, 2024 (E) & 2034 (F) |
Figure 13: India Blood Transfusion Products Market Y-o-Y Analysis (%), By End User, 2024-2034 |
Figure 14: India Blood Transfusion Products Market - Historical, Forecast Market Sizes (US$ Mn), By End User, 2019 - 2034 |
Figure 15: India Blood Transfusion Products Market Attractiveness Analysis By End User, 2024–2034 |
Figure 16: India Blood Transfusion Products Market Share Analysis (%), By End User Type, 2024 (E) & 2034 (F) |
Figure 17: India Blood Transfusion Products Market Y-o-Y Analysis (%), By End User Type, 2024-2034 |
Figure 18: India Blood Transfusion Products Market - Historical, Forecast Market Sizes (US$ Mn), By End User Type, 2019 - 2034 |
Figure 19: India Blood Transfusion Products Market Attractiveness Analysis By End User Type, 2024–2034 |
List of Tables: India Blood Transfusion Products Market |
Table 01: India Blood Transfusion Products Market Size (US$ Mn) Historical (2019-2023) and Forecast 2024–2034 Analysis, By Product Type |
Table 02: India Blood Transfusion Products Market Size (US$ Mn) Historical (2019-2023) and Forecast 2024–2034 Analysis, By End User |
Table 03: India Blood Transfusion Products Market Size (US$ Mn) Historical (2019-2023) and Forecast 2024-2034 By End User Type |
Key Market Players